KNUTSEN; Lars J.S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for KNUTSEN; Lars J.S..The latest application filed is for "compounds for the treatment of neuromuscular disorders".
- KNUTSEN; Lars J.S. - Essex GB
- Knutsen; Lars J. S. - West Chester PA US
- Knutsen; Lars J. S. - Vedb.ae butted.k DK
- Knutsen; Lars J. S. - Vedb k DK
- Knutsen; Lars J. S. - Vedbaek DK
| Patent | Date |
|---|---|
| Compounds For The Treatment Of Neuromuscular Disorders App 20220306564 - KELLY; Nicholas ; et al. | 2022-09-29 |
| 5-[(1s)-1-(4-bromophenoxy)ethyl]-2h-tetrazole Derivatives And Related Compounds As Clc-1 Ion Channel Inhibitors For Treating Neuromuscular Disorders App 20220274938 - KNUTSEN; Lars J.S. ; et al. | 2022-09-01 |
| Compounds for the treatment of neuromuscular disorders Grant 11,147,788 - Knutsen , et al. October 19, 2 | 2021-10-19 |
| Compounds for the treatment of neuromuscular disorders Grant 10,385,028 - Knutsen , et al. A | 2019-08-20 |
| Compounds For The Treatment Of Neuromuscular Disorders App 20190183863 - Knutsen; Lars J.S. ; et al. | 2019-06-20 |
| Compounds For The Treatment Of Neuromuscular Disorders App 20190185437 - Knutsen; Lars J.S. ; et al. | 2019-06-20 |
| Compounds For The Treatment Of Neuromuscular Disorders App 20190185409 - Knutsen; Lars J.S. ; et al. | 2019-06-20 |
| Compounds For The Treatment Of Neuromuscular Disorders App 20190183834 - Pedersen; Thomas Holm ; et al. | 2019-06-20 |
| Compounds For The Treatment Of Neuromuscular Disorders App 20190183812 - Knutsen; Lars J.S. ; et al. | 2019-06-20 |
| Compounds For The Treatment Of Neuromuscular Disorders App 20190183833 - Knutsen; Lars J.S. ; et al. | 2019-06-20 |
| Substituted pyridazine derivatives Grant 8,912,183 - Hudkins , et al. December 16, 2 | 2014-12-16 |
| Pyridazinone Derivatives App 20140142088 - Bacon; Edward R. ; et al. | 2014-05-22 |
| Methods of treating disorders mediated by histamine H.sub.3 receptors using pyridazinone derivatives Grant 8,673,916 - Bacon , et al. March 18, 2 | 2014-03-18 |
| Aryl pyridazinone derivatives and their use as H3 receptor ligands Grant 8,586,588 - Bacon , et al. November 19, 2 | 2013-11-19 |
| Pyridazinone derivatives Grant 8,207,168 - Becknell , et al. June 26, 2 | 2012-06-26 |
| Substituted Pyridazine Derivatives App 20120004231 - Hudkins; Robert L. ; et al. | 2012-01-05 |
| Substituted pyridazine derivatives Grant 8,076,331 - Hudkins , et al. December 13, 2 | 2011-12-13 |
| Pyridazinone Derivatives App 20110288075 - Bacon; Edward R. ; et al. | 2011-11-24 |
| Substituted pyridazine derivatives App 20100311752 - Hudkins; Robert L. ; et al. | 2010-12-09 |
| Pyridazinone Derivatives App 20100280007 - Bacon; Edward R. ; et al. | 2010-11-04 |
| Pyridazinone Derivatives App 20100273779 - Bacon; Edward R. ; et al. | 2010-10-28 |
| 2,5',N6-trisubstituted adenosine derivatives Grant 5,589,467 - Lau , et al. December 31, 1 | 1996-12-31 |
| C2,N.sup.6 -disubstituted adenosine derivatives Grant 5,432,164 - Knutsen , et al. July 11, 1 | 1995-07-11 |
| 2-chloro-N.sup.6 -substituted adenosines, their pharmaceutical compositions, and activity in treating ischemias Grant 5,430,027 - Knutsen , et al. July 4, 1 | 1995-07-04 |
| N-substituted azaheterocyclic carboxylic acids Grant 5,348,965 - Andersen , et al. September 20, 1 | 1994-09-20 |
| Azacyclic carboxylic acid derivatives and their preparation and use Grant 5,231,106 - Knutsen , et al. July 27, 1 | 1993-07-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 